The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
Abstract
NF-kappaB (nuclear factor-kappaB) is a collective name for inducible dimeric transcription factors composed of members of the Rel family of DNA-binding proteins that recognize a common sequence motif. NF-kappaB is found in essentially all cell types and is involved in activation of an exceptionally large number of genes in response to infections, inflammation, and other stressful situations requiring rapid reprogramming of gene expression. NF-kappaB is normally sequestered in the cytoplasm of nonstimulated cells and consequently must be translocated into the nucleus to function. The subcellular location of NF-kappaB is controlled by a family of inhibitory proteins, IkappaBs, which bind NF-kappaB and mask its nuclear localization signal, thereby preventing nuclear uptake. Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkappaB, which frees NF-kappaB to translocate to the nucleus where it regulates gene transcription. NF-kappaB activation represents a paradigm for controlling the function of a regulatory protein via ubiquitination-dependent proteolysis, as an integral part of a phosphorylationbased signaling cascade. Recently, considerable progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1. The multisubunit Ika…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of its ability to regulate the expression of inflammatory proteins, NFκB is believed to play a major role in the inflammatory process.”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
In the citing paper
“NFκB-induced gene expression requires that NFκB not only becomes activated, but it must also be phosphorylated and must physically translocate from cytoplasm to the nucleus (Karin and Ben-Neriah, 2000).”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The N-end rule: functions, mysteries, uses
Varshavsky, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12142 · Cited by 859
A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway
Belvin, M. P., & Anderson, K. V. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.393 · Cited by 836
A common human skin tumour is caused by activating mutations in β-catenin
Chan, E., Gat, U., McNiff, J. M., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/7747 · Cited by 612
A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB
Lee, S.-J., Dimtchev, A., Lavin, M. F., Dritschilo, A., & Jung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202088 · Cited by 136
Research works printed but not linked: 229
- 10.1016/0092-8674(86)90807-X · DOI
- Baldwin AS. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–81 · DOI
- Ghosh S, May MJ, Kopp EB. 1998. NFκB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–60 · DOI
- 10.1016/S0065-230X(08)60257-2 · DOI
- 10.1146/annurev.cb.10.110194.002201 · DOI
- 10.1006/scbi.1997.0060 · DOI
- Whiteside ST, Israël A. 1997. I κ B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75–82 · DOI
- 1997, J. Cell Sci., 110, 369, 10.1242/jcs.110.3.369 · DOI
- 10.1128/MCB.16.5.2341 · DOI
- 10.1101/gad.9.22.2736 · DOI
- 10.1084/jem.188.6.1055 · DOI
- 10.1038/34356 · DOI
- 10.1038/nsb0198-67 · DOI
- 10.1038/373303a0 · DOI
- 10.1038/373311a0 · DOI
- 10.1016/S0092-8674(00)81699-2 · DOI
- 10.1016/S0092-8674(00)81698-0 · DOI
- 10.1016/S0065-2776(08)60742-7 · DOI
- 10.1056/NEJM199704103361506 · DOI
- 10.1146/annurev.biochem.67.1.227 · DOI · Paper page
- 10.1146/annurev.immunol.15.1.749 · DOI · Paper page
- 1995, Microbiol. Rev., 59, 481, 10.1128/mr.59.3.481-505.1995 · DOI
- 10.1006/meth.1998.0646 · DOI
- Baichwal VR, Baeuerle PA. 1997. Activate NF-κB or die? Curr. Biol. 7:R94–96 · DOI
- 10.1006/scbi.1997.0062 · DOI
- 1996, Oncogene, 13, 1367
- 10.1006/scbi.1997.0061 · DOI
- Grilli M, Memo M. 1999. NF-κB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57:1–7 · DOI
- 10.1073/pnas.95.14.8211 · DOI
- 10.1183/09031936.98.12010221 · DOI
- 10.1136/gut.43.6.856 · DOI
- 10.1128/MCB.15.5.2809 · DOI
- 10.1126/science.7878466 · DOI · Paper page
- 10.1128/MCB.15.3.1302 · DOI · Paper page
- 10.1128/MCB.16.4.1295 · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb07287.x · DOI
- 10.1128/MCB.15.10.5339 · DOI
- 10.1038/25159 · DOI
- 10.1016/S0092-8674(00)80752-7 · DOI
- 10.1101/gad.13.5.505 · DOI
- 10.1101/gad.9.13.1586 · DOI
- 10.1073/pnas.92.24.11259 · DOI
- 10.1074/jbc.271.1.376 · DOI
- 10.1073/pnas.92.23.10599 · DOI
- Lin Y-C, Brown K, Siebenlist U. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB: Signal-induced phosphorylation of IκB alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:3003–9 · DOI
- 10.1016/S0092-8674(00)80153-1 · DOI
- 10.1073/pnas.96.2.429 · DOI
- 10.1093/emboj/17.17.5170 · DOI
- 10.1073/pnas.95.22.13012 · DOI
- 10.1038/41493 · DOI · Paper page
- Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: cytokineactivated IκB kinases essential for NFκB activation. Science 278:860–66 · DOI
- 10.1016/S0092-8674(00)81064-8 · DOI
- 10.1016/S0092-8674(00)81842-5 · DOI
- 10.1016/S0092-8674(00)80406-7 · DOI
- 10.1016/S0092-8674(00)80344-X · DOI
- 10.1126/science.278.5339.866 · DOI
- 1995, Cell. Mol. Biol. Res., 41, 537
- 10.1038/26261 · DOI
- 10.1016/S0092-8674(00)81466-X · DOI
- 10.1128/MCB.19.2.1526 · DOI
- 10.1073/pnas.96.3.1042 · DOI
- 1990, J. Immunol., 145, 3080, 10.4049/jimmunol.145.9.3080 · DOI
- 10.1038/26254 · DOI
- 10.1046/j.1432-1327.1999.00028.x · DOI
- 10.1016/S1097-2765(00)80179-3 · DOI
- Zandi E, Chen Y, Karin M. 1998. Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science 281:1360–63 · DOI
- 10.1126/science.284.5412.321 · DOI
- 10.1084/jem.189.11.1839 · DOI
- 10.1016/S1074-7613(00)80042-4 · DOI
- 10.1074/jbc.274.22.15297 · DOI
- 10.1074/jbc.273.20.12041 · DOI
- 10.1074/jbc.273.46.30736 · DOI
- 10.1073/pnas.95.7.3792 · DOI
- 10.1126/science.284.5412.309 · DOI
- 10.1016/S0092-8674(00)81092-2 · DOI
- 10.1128/MCB.19.3.2180 · DOI
- 10.1128/MCB.18.10.5899 · DOI
- 10.1038/43474 · DOI · Paper page
- 10.1038/43466 · DOI · Paper page
- 10.1128/MCB.18.12.7336 · DOI
- 10.1073/pnas.95.16.9319 · DOI
- 10.1128/MCB.19.1.21 · DOI
- 10.1023/A:1021925629248 · DOI
- 10.1038/18465 · DOI
- 10.1074/jbc.274.15.10641 · DOI
- 10.1038/385540a0 · DOI
- Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factorκB and c-jun N-terminal kinase (JNK/ SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94:9792–96 · DOI
- Baud V, Liu Z-G, Bennett B, Suzuki N, Xia Y, Karin M. 1999. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an N-terminal effector domain. Genes Dev. 13:1297– 308 · DOI
- 10.1126/science.284.5412.316 · DOI
- 10.1126/science.284.5412.313 · DOI
- 10.1038/8780 · DOI
- 10.1093/intimm/8.1.23 · DOI
- 10.1101/gad.12.21.3369 · DOI
- 10.1016/S1074-7613(00)80390-8 · DOI
- 10.1016/S1074-7613(00)80391-X · DOI
- 10.1073/pnas.95.5.2307 · DOI
- 10.1146/annurev.ge.29.120195.002103 · DOI
- 10.1101/gad.5.10.1892 · DOI
- 10.1016/0092-8674(91)90014-P · DOI
- 10.1038/ng0197-42 · DOI
- 10.1038/ng0197-36 · DOI
- 10.1038/376167a0 · DOI
- 10.1016/S1074-7613(00)80451-3 · DOI
- 10.1073/pnas.96.6.2994 · DOI
- Vandenabeele P, Declercg W, Beyaert R, Fiers W. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 5:392–99 · DOI · Paper page
- 10.1038/sj.onc.1202568 · DOI
- 10.1016/S0898-6568(98)00018-7 · DOI
- 10.1073/pnas.90.13.6155 · DOI
- Auron PE. 1998. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:221–37 · DOI
- 10.1016/S1074-7613(00)80535-X · DOI · Paper page
- 10.1074/jbc.270.23.13757 · DOI
- Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837–47 · DOI
- Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin1 receptor. Science 271:1128–31 · DOI
- 10.1126/science.278.5343.1612 · DOI
- 10.1038/383443a0 · DOI
- 10.1101/gad.12.18.2821 · DOI
- 10.1016/S1359-6101(98)00023-9 · DOI
- 10.1038/19110 · DOI
- 10.1126/science.7544915 · DOI
- Liu Z-G, Hu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 87:565– 76 · DOI · Paper page
- Takeuchi M, Rothe M, Goeddel DV. 1996. Anatomy of TRAF2: distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 16:19935–42 · DOI
- 10.1074/jbc.271.25.14661 · DOI
- 10.1101/gad.13.8.1015 · DOI
- 10.1074/jbc.273.35.22681 · DOI
- 10.1074/jbc.272.51.32102 · DOI
- 10.1126/science.275.5296.90 · DOI
- 10.1016/S1097-2765(00)80283-X · DOI
- 10.1016/S0959-437X(96)80062-1 · DOI
- 10.1006/scbi.1997.0059 · DOI
- 10.1006/dbio.1996.0308 · DOI
- 10.1038/35154 · DOI · Paper page
- 10.1016/S0014-5793(99)00322-1 · DOI
- 10.1042/0264-6021:3390227 · DOI
- 10.1016/S0952-7915(99)80003-X · DOI
- 10.1126/science.284.5418.1313 · DOI
- 10.1038/32195 · DOI
- Dushay MS, Asling B, Hultmark D. 1996. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. USA 93:10343–47 · DOI
- Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367–80 · DOI
- 10.1146/annurev.genet.30.1.405 · DOI
- 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
- 10.1016/S0968-0004(97)01122-5 · DOI
- 10.1096/fasebj.11.14.9409544 · DOI
- 10.1016/0092-8674(93)90384-3 · DOI
- 10.1093/emboj/16.21.6325 · DOI · Paper page
- 10.1038/373081a0 · DOI
- 10.1038/10039 · DOI
- Zachariae W, Nosmyth K. 1999. Whose end is destruction: cell cycle division and the anaphase promoting complex. Genes Dev. 13:2039–58 · DOI
- Yamano H, Tsurumi C, Gannon J, Hunt T. 1998. The role of the destruction box and its neighbouring lysine residues in cyclin B for anaphase ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor. EMBO J. 17:5670– 78 · DOI
- 10.1016/S1097-2765(00)80126-4 · DOI
- 10.1016/S1097-2765(00)80286-5 · DOI
- Peters JM. 1998. SCF and APC: the yin and yang of cell cycle regulated proteolysis. Curr. Opin. Cell. Biol. 10:759–68 · DOI
- Patton EE, Willems AR, Tyers M. 1998. Combinatorial control in ubiquitindependent proteolysis: Don't Skp the Fbox hypothesis. Trends Genet. 14:236– 43 · DOI
- 10.1101/gad.13.12.1614 · DOI
- 10.1016/S1097-2765(00)80482-7 · DOI
- 10.1126/science.284.5414.657 · DOI
- 10.1038/20459 · DOI · Paper page
- 10.1128/MCB.18.2.732 · DOI
- 10.1126/science.284.5414.662 · DOI
- 10.1128/MCB.16.3.1058 · DOI
- 10.1093/emboj/16.21.6486 · DOI
- 10.1101/gad.7.7a.1266 · DOI
- 10.1002/j.1460-2075.1993.tb06157.x · DOI
- 10.1093/emboj/16.13.3797 · DOI
- 10.1126/science.275.5307.1790 · DOI
- 10.1126/science.275.5307.1787 · DOI
- 1998, Cancer Res., 58, 1344
- 10.1002/(SICI)1098-2264(199805)22:1<37::AID-GCC5>3.3.CO;2-P · DOI
- 1998, Cancer Res., 58, 2524
- 1998, Cancer Res., 58, 896
- 1998, Cancer Res., 58, 2520
- 1998, Cancer Res., 58, 1130
- 10.1073/pnas.95.15.8847 · DOI
- Spevak W, Keiper BD, Stratowa C, Castanon MJ. 1993. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats. Mol. Cell. Biol. 13:4953–66. Erratum. 1993. 13(11):7199 · DOI
- 10.1016/S1097-2765(00)80056-8 · DOI
- 10.1006/bbrc.1999.0289 · DOI
- 10.1073/pnas.96.7.3859 · DOI
- 10.1074/jbc.274.12.7941 · DOI
- 10.1101/gad.13.3.284 · DOI
- 10.1101/gad.13.21.2751 · DOI
- 10.1038/sj.onc.1202760 · DOI
- 10.1016/S0092-8674(00)81376-8 · DOI
- 1996, Nature, 379, 847
- 10.1038/360597a0 · DOI
- 10.1006/geno.1999.5792 · DOI
- 10.1016/S0960-9822(99)80091-8 · DOI
- 10.1093/emboj/18.9.2401 · DOI
- 10.1038/sj.onc.1202653 · DOI
- 10.1073/pnas.96.11.6273 · DOI
- 10.1016/S0925-4773(98)00134-8 · DOI
- 10.1016/S0304-419X(97)00008-5 · DOI
- 10.1016/S0165-4608(97)00479-2 · DOI
- 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.3.CO;2-R · DOI
- 10.1038/sj.onc.1202073 · DOI
- 10.1126/science.274.5288.782 · DOI · Paper page
- Wang C-Y, Mayo MW, Baldwin AS Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784–87 · DOI
- 10.1016/S0092-8674(00)81409-9 · DOI
- 10.1038/354395a0 · DOI
- 10.1016/S0092-8674(94)90482-0 · DOI
- Orian A, Whiteside S, Israël A, Stancovski I, Schwartz AL, Ciechanover A. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105: reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol. Chem. 270:21707– 14 · DOI
- 10.1074/jbc.273.15.8820 · DOI
200 of 229 shown
Cited by
Sorted by citations
Items 401–500 of 1,071
Shi, H., Yao, R., Lian, S., Liu, P., Liu, Y., Yang, Y., Yang, H.-M., & Li, S.-Z. (2019) · Stress · doi:10.1080/10253890.2019.1568987 · Cited by 28
“When a cell receives any number of extracellular signals, the phosphorylation of IjB leads to its ubiquitination and proteasomal degradation, freeing the NFjB/Rel complexes (Karin & Ben-Neriah, 2000).”
BackgroundJean, M. J., Fiches, G. N., Hayashi, T., & Zhu, J. K. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0153 · Cited by 31
The IκB kinase complex is a regulator of mRNA stability
Mikuda, N., Kolesnichenko, M., Beaudette, P., Popp, O., Uyar, B., Sun, W., Tufan, A. B., Perder, B., Akalin, A., Chen, W., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798658 · Cited by 35
“NF-κB drives transcription of diverse target genes regulating processes including cell proliferation and differentiation, apoptosis, autophagy, senescence and inflammation [1, 3].”
Sakamoto, T., Ohashi, W., Tomita, K., Hattori, K., Matsuda, N., & Hattori, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.021 · Cited by 28
Preventive effect of apigenin against isoproterenol‐induced apoptosis in cardiomyoblasts
Radhiga, T., Robert, B. M., Sundaresan, A., Govindasamy, K., & Nagarajan, R. P. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22213 · Cited by 34
Li, H., Chen, X., & Zhou, S. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.01.011 · Cited by 29
TRAF6 is a novel NS3-interacting protein that inhibits classical swine fever virus replication
Lv, H., Dong, W., Cao, Z., Li, X., Wang, J., Qian, G., Lv, Q.-Z., Wang, C.-B., Guo, K., & Zhang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-06934-1 · Cited by 28
Phospholipase Cγ2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis
Chen, Y., Wang, X., Di, L., Fu, G., Chen, Y., Bai, L., Liu, J., Feng, X., McDonald, J. M., Michalek, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802493200 · Cited by 27
SCFFbw7 Modulates the NFκB Signaling Pathway by Targeting NFκB2 for Ubiquitination and Destruction
Fukushima, H., Matsumoto, A., Inuzuka, H., Zhai, B., Lau, A., Wan, L.-X., Gao, D.-M., Shaik, S., Yuan, M., Gygi, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115626 · Cited by 27
Role of pyroptosis in diabetic cardiomyopathy: an updated review
Wang, G., Ma, T., Huang, K., Zhong, J.-H., Lu, S., & Li, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1322907 · Cited by 27
“However, IKK b phosphorylation can ubiquitinate I k B a , resulting in its dissociation from NF-k B (36, 37).”
BackgroundKim, S. L., Shin, M.-W., Seo, S., & Kim, S. W. (2022) · Bioscience Reports · doi:10.1042/bsr20212418 · Cited by 27
Cinnamon and Eucalyptus Oils Suppress the Inflammation Induced by Lipopolysaccharide In Vivo
Zhao, C., Cao, Y., Zhang, Z., Nie, D., & Li, Y. (2021) · Molecules · doi:10.3390/molecules26237410 · Cited by 33
“NF-κB is an important transcription factor required for expression of many cytokines involved in inflammation stimulated by LPS [56].”
BackgroundPontecorvi, P., Banki, M. A., Zampieri, C., Zalfa, C., Azmoon, P., Kounnas, M., Marchese, C., Gonias, S., & Mantuano, E. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1657-3 · Cited by 27
Li, C., Bian, Y., Feng, Y., Tang, F., Wang, L., Hoi, M. P. M., Ma, D., Zhao, C., & Lee, S. M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00713 · Cited by 34
Wu, X., Kong, Q., Xia, Z., Zhan, L., Duan, W., & Song, X. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4117 · Cited by 16
“The activated NF-κB in the nucleus promotes the transcription of specific targeting genes, including the pro‑inflammatory cytokines TNF-α, IL-6 and IL-1β (29-31).”
BackgroundInfluentialEndothelial Atg7 Deficiency Ameliorates Acute Cerebral Injury Induced by Ischemia/Reperfusion
Wang, H., Wei, J., Liu, D., Zhuang, S., Li, Y., Liu, H., Ban, M., Fang, W., Cao, L., Zhao, W., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00998 · Cited by 31
Vishnu, K. V., Ajeeshkumar, K. K., Chatterjee, N. S., Lekshmi, R. G. K., Sreerekha, P. R., Mathew, S., & Ravishankar, C. N. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0834-5 · Cited by 28
Petersheim, D., Massaad, M. J., Lee, S., Scarselli, A., Cancrini, C., Moriya, K., Sasahara, Y., Lankester, A. C., Dorsey, M. J., Giovanni, D. D., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.030 · Cited by 32
“The released p50:p65 complex translocates into the nucleus, where it induces transcription of genes that mediate the inflammatory response.(13,14) The noncanonical NF-kB pathway is used by a limited range of cell-surface receptors, including lymphotoxin b receptor (LTbR), B-cell activating factor receptor, and CD40.”
Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1
Atef, Y., El-Fayoumi, H. M., Abdel-mottaleb, Y., & Mahmoud, M. F. (2017) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-017-1389-9 · Cited by 27
Park, J., Kim, M., Na, G., Jeon, I., Kwon, Y.-K., Kim, J.-H., Youn, H., & Koo, Y. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.08.002 · Cited by 26
Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis
Ikura, H., Endo, J., Kitakata, H., Moriyama, H., Sano, M., & Fukuda, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116336 · Cited by 26
The Dangerous Liaisons in the Oxidative Stress Response to Leishmania Infection
Reverte, M., Snäkä, T., & Fasel, N. J. (2022) · Pathogens · doi:10.3390/pathogens11040409 · Cited by 30
“In contrast, in stimulatory conditions, such as infection, exposure to pro-inflammatory cytokines and oxidative species [82,83] will lead to the first step of NF-κB activation requiring post-translation modification of IκB inhibitors.”
BackgroundChen, P., Bai, Q., Wu, Y., Zeng, Q., Song, X., Guo, Y., Zhou, P., Wang, Y., Liao, X., Wang, Q.-L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.712907 · Cited by 22
“Phosphorylated IκBα is ubiquitinated and translocated to the proteosome for degradation, which causes the release of p65 and exposure of nuclear-located guide peptides (Karin and Ben-Neriah, 2000).”
BackgroundMitochondria and the Frozen Frog
Storey, J., Wu, S.-B., & Storey, K. (2021) · Antioxidants · doi:10.3390/antiox10040543 · Cited by 26
“Under normal unstressed conditions, NF-κB is held in the cytoplasm by its inhibitory protein, IκB, but when ROS levels rise, IκB is phosphorylated, ubiquitinated and targeted for degradation, leaving NF-κB free to translocate into the nucleus and upregulate antioxidant genes [10].”
BackgroundSang, L.-X., Kang, K., Sun, Y., Li, Y.-L., & Chang, B. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107572 · Cited by 26
Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis
Melton, E. M., & Qiu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186458 · Cited by 28
“kappa-light-chain-enhancer of activated B cells (NFKB) dependent upregulation of pro-inflammatory gene expression (Figure 1) [31,37].”
BackgroundDeterminants of Sensitivity to Radiotherapy in Endometrial Cancer
Sorolla, M. A., Parisi, E., & Sorolla, A. (2020) · Cancers · doi:10.3390/cancers12071906 · Cited by 27
Białek, K., Czarny, P., Watała, C., Wigner, P., Talarowska, M., Gałecki, P., Szemraj, J., & Śliwiński, T. (2020) · PeerJ · doi:10.7287/peerj.8676v0.1/reviews/1
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control
Namineni, S., O'Connor, T., Faure-Dupuy, S., Johansen, P., Riedl, T., Liu, K.-J., Xu, H.-F. C., Singh, I., Shinde, P. V., Li, F.-H., et al. (2020) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/s-0039-3402260 · Cited by 26
“The IKK complex consists of two catalytic 11 kinase subunits, IKKα and IKKβ with intrinsic kinase activities and a regulatory 12 subunit, IKKγ, also known as NF-κB essential modulator (NEMO) with helix-loop 13 helix and leucine-zipper motifs that mediate protein-protein interactions (15, 16).”
BackgroundSelf-citationWang, P.-W., Hou, Y., Zhang, W., Zhang, H.-T., Che, X.-H., Gao, Y., Liu, Y., Yang, D., Wang, J.-M., Xiang, R.-W., et al. (2019) · Inflammation · doi:10.1007/s10753-019-01047-5 · Cited by 26
Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus
Acchioni, C., Remoli, A. L., Marsili, G., Acchioni, M., Nardolillo, I., Orsatti, R., Farcomeni, S., Palermo, E., Perrotti, E., Barreca, M. L., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00495-19 · Cited by 26
“Five members of the family, C-Rel, RelA (p65), RelB, NF- B1 (p50 and its precursor, p105), and NF- B2 (p52 and its precursor, p100), exist as homodimers or heterodimers in quiescent or unstimulated cells, in association with the inhibitory inhibitor of nuclear factor B (I B), in particular, I B- , which maintains the…”
BackgroundRole of the COP9 Signalosome (CSN) in Cardiovascular Diseases
Milic, J., Tian, Y., & Bernhagen, J. (2019) · Biomolecules · doi:10.3390/biom9060217 · Cited by 27
“In the context of this review article, substrate receptor F-box protein/‘to-be-degraded-substrate’ pairs related to cell cycle progression, inflammatory signaling, or hypoxic stress such as SCFβ-TRCP1/IκB-α, SCFβ-TRCP1/Wee1, SCFβ-TRCP1/Cdc25A, Cul3KEAP1/Nrf2, SCFSkp2/p27, or Cul2VHL/HIF-1α, respectively, are of partic…”
BackgroundInfluentialJiang, K., Shi, J., & Shi, J. (2019) · Cellular and molecular neurobiology · doi:10.1007/s10571-019-00679-3 · Cited by 26
Wu, X., Tang, B.-Q., Liao, X., Su, Z., Lee, S. M., Cai, Y., & Li, C. (2019) · Food & Function · doi:10.1039/c8fo02474j · Cited by 29
A20 Orchestrates Inflammatory Response in the Oral Mucosa through Restraining NF-κB Activity
Li, Y., Mooney, E. C., Holden, S. E., Xia, X., Cohen, D. J., Walsh, S. W., Ma, A. I., & Sahingur, S. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801286 · Cited by 27
Xing, J., Wang, X., Lan, Y., Lou, J., Ma, B., Zhu, T., Zhang, H., Wang, D., Yu, Z., Yuan, Z., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2013 · Cited by 27
Hoeger, B., Serwas, N. K., & Boztuǧ, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01978 · Cited by 30
Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment
Fouani, L., Kovačević, Ž., & Richardson, D. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7387 · Cited by 26
“…of the catalytic portion of the I jja / b component activates this complex, which may then use its inherent kinase activity to double phosphorylate the I j B a inhibitory protein on its substrate recognition sites (serine-32 and serine-36 for I j B a ) (125, 157, 225, 320, 340, 356, 370).”
Franz, S., Rennert, P., Woznik, M., Grützke, J., Lüdde, A., País, E. M. A., Finsterbusch, T., Geyer, H., Mankertz, A., & Friedrich, N. (2017) · Journal of Virology · doi:10.1128/jvi.01037-17 · Cited by 26
“Consequently, p65 is transported into the nucleus and binds to its specific target DNA sequences (28).”
BackgroundHuang, Y., & Fang, W. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01152-9 · Cited by 30
Yang, J., Tang, X., Li, B.-Q., & Shi, J. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00971-8 · Cited by 25
“Then, NF-κB translocates to the nucleus; and binds to specific elements located in the promoters of various genes, such as inflammatory factors, and adhesion molecules [13, 14].”
BackgroundPaclitaxel resistance is mediated by NF‑κB on mesenchymal primary breast cancer cells
Esparza‐López, J., Longoria, O., la Cruz-Escobar, E. N. D., Garibay-Díaz, J. C., León‐Rodríguez, E., & Ibarra-Sánchez, M. D. J. (2021) · Oncology Letters · doi:10.3892/ol.2021.13168 · Cited by 25
“Next, NF‐κB is translocated to the nucleus where it regulates the expression of its target genes (19).”
Kanso, F., Khalil, A., Noureddine, H., & El-Makhour, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107778 · Cited by 40
Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action
Akter, Z., Ahmed, F. H., Tania, M., & Khan, M. A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191011143642 · Cited by 33
Провоспалительные цитокины и заживление кожных ран у мышей
Nosenko, M. A., Амбарян, С. Г., & Друцкая, М. С. (2019) · Molecular Biology · doi:10.1134/s0026898419050136 · Cited by 46
Jiang, Z., Peng, T., Qian, H.-L., Lu, C., Qiu, F., & Zhang, S.-Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0878-y · Cited by 25
Guan, Z., Tao, Y., Zhang, X., Guo, Q., Liu, Y., Zhang, Y., Wang, Y., Ji, G., Wu, G., Wang, N., et al. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12691 · Cited by 30
Chapela, S. P., Simancas‐Racines, D., Montalván, M., Frías-Toral, E., Simancas-Racines, A., Muscogiuri, G., Barrea, L., Sarno, G., Martinez, P. I., Reberendo, M. J., et al. (2023) · Nutrients · doi:10.3390/nu15051071 · Cited by 28
Wang, F., Liu, J.-T., An, Q., Wang, Y., Yang, Y., Huo, T., Yang, S.-Q., Ju, R.-J., & Quan, Q. (2023) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s391741 · Cited by 24
From the Evasion of Degradation to Ubiquitin-Dependent Protein Stabilization
Ahmad, Y. A., Oknin-Vaisman, A., Bitman-Lotan, E., & Orian, A. (2021) · Cells · doi:10.3390/cells10092374 · Cited by 26
“For example, upon immune challenge, signal-induced phosphorylation of the inhibitory protein, IκBα, converts the extremely stable protein into a rapidly degraded phospho-protein, enabling immune response [8,9].”
BackgroundSaahene, R. O., Agbo, E., Barnes, P., Yahaya, E. S., Amoani, B., Nuvor, S. V., & Okyere, P. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4514342 · Cited by 27
Immunoproteasome Function in Normal and Malignant Hematopoiesis
Santamaría, N. T., Ebstein, F., Heidel, F. H., & Krüger, E. (2021) · Cells · doi:10.3390/cells10071577 · Cited by 25
Kim, J.-Y., Leem, J., & Hong, H.-L. (2020) · Antioxidants · doi:10.3390/antiox9070585 · Cited by 24
“Phosphorylated IkB is subsequently ubiquitinated and degraded by the proteasomal pathway, thus allowing NF-kB to translocate into the nucleus, where it modulates the expression of inflammatory target genes [24].”
BackgroundMou, T., Luo, Y., Huang, Z., Zheng, D., Pu, X., Shen, A., Pu, J., Li, T., Dai, J., Chen, W., et al. (2020) · Innate Immunity · doi:10.1177/1753425920928449 · Cited by 25
Tran, H. M., Kim, D.-C., Sohn, J., Yim, J., & Oh, H. (2020) · Marine Drugs · doi:10.3390/md18050247 · Cited by 24
PCAT‐1 promotes cell growth by sponging miR‐129 via MAP3K7/NF‐κB pathway in multiple myeloma
Shen, X., Kong, S., Yang, Q., Yin, Q., Cong, H., Wang, X., & Ju, S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15035 · Cited by 26
Choe, S.-H., Choi, E., Hyeon, J.-Y., Keum, B. R., Choi, I. S., & Kim, S. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105750 · Cited by 24
Glucocorticoids delay RAF-induced senescence promoted by EGR1
Carvalho, C., L’Hôte, V., Courbeyrette, R., Kratassiouk, G., Pinna, G., Cintrat, J., Wilkes, C. D., Derbois, C., Olaso, R., Deleuze, J., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.230748 · Cited by 27
“…in RAF-induced proliferative arrest by constructing a version of our BJhTert/ptetON-B-RAF-V600E cell line that expresses the IκB-SR (super repressor), a mutant version of IκB that acts as a dominant-negative suppressor of NF-κB by sequestering RelA in the cytoplasm (Karin and Ben-Neriah, 2000).”
BackgroundFroehlich, T. C., Müller-Decker, K., Braun, J., Albrecht, T., Schroeder, A. E., Gülow, K., Goerdt, S., Krammer, P., & Nicolay, J. (2019) · Blood · doi:10.1182/blood.2019001545 · Cited by 24
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis
da Silva, S. D., Xu, B., Maschietto, M. C., Marchi, F. A., Alkailani, M. I., Bijian, K., Xiao, D., & Alaoui‐Jamali, M. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1261 · Cited by 28
“Activated IKKs thus phosphorylate IkBs at serine residues 32 and 36, leading to their degradation and the subsequent activation of NF-kB (23, 26).”
BackgroundLi, B., Fang, J. S., Zuo, Z., Yin, S., He, T., Yang, M., Deng, J., Shen, L., Ma, X., Yu, S., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.04.002 · Cited by 23
Wu, Z., Neufeld, H. L. D., Torlakovic, E., & Xiao, W. (2018) · OncoTarget · doi:10.18632/oncotarget.24640 · Cited by 24
Cai, B.-X., Bai, Q.-L., Chi, X., Goraya, M. U., Wang, L., Wang, S.-L., Chen, B., & Chen, J.-L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02558 · Cited by 24
A novel statistical approach for identification of the master regulator transcription factor
Sikdar, S., & Datta, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1499-x · Cited by 24
Zeng, Y.-D., Cao, W., Huang, Y., Zhang, H., Li, C., He, J.-Z., Liu, Y.-Q., Gong, H.-X., & Su, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117765 · Cited by 23
She, R., Luo, J., & Weissman, J. S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad329 · Cited by 28
Small molecules of herbal origin for osteoarthritis treatment: in vitro and in vivo evidence
Zhang, P., Li, K., Kamali, A., Ziadlou, R., Ahmad, P., Wang, X.-L., Richards, R., Alini, M., Basoli, V., Li, Z., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02785-y · Cited by 23
Alghamdi, S. S., Suliman, R. S., Aljammaz, N. A., Kahtani, K. M., Aljatli, D., & Albadrani, G. M. (2022) · Plants · doi:10.3390/plants11040549 · Cited by 29
“The activation of NF-κB results in the phosphorylation of NF-κB inhibitor, IκB, via the IκB kinase (IKK) signalosome complex leading to transcription of pro-inflammatory mediators, such as iNOS, COX-2, TNF-α, and IL-1β [80,81] Therefore, inhibiting the NF-κB will suppress the release of these inflammatory markers, whi…”
BackgroundLiu, X., Su, J., Wang, G., Zheng, L.-H., Wang, G.-N., Sun, Y., Bao, Y.-L., Wang, S., & Huang, Y.-X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212128 · Cited by 23
Zhou, C., Zhang, X., Ruan, C., & Cheang, W. S. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00480-9 · Cited by 25
Mann, M. W., Roberts, D. S., Zhu, Y., Li, Y., Zhou, J., Ge, Y., & Brasier, A. R. (2021) · Viruses · doi:10.3390/v13030454 · Cited by 23
“BRD4-dependent transcriptional elongation involves the coordinated actions 47 of histone acetyl transferases [15,16], cyclin dependent kinases [8] and ubiquitin ligases 48 [17] that dissociate elongation factors and stimulate polymerase processivity.”
BackgroundYang, J., Cao, M., Hu, W.-Y., Wei, Y.-Y., & Hu, T.-J. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.128 · Cited by 23
A20 Restricts Inflammatory Response and Desensitizes Gingival Keratinocytes to Apoptosis
Li, Y., Mooney, E. C., Xia, X., Gupta, N., & Sahingur, S. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00365 · Cited by 24
Fang, X., Liao, R., Yu, Y., Li, J., Guo, Z., & Zhu, T. (2019) · Mediators of Inflammation · doi:10.1155/2019/4952131 · Cited by 27
“It was well known that NF-κB and MAPK cell signaling pathways play an important role in the process of inflammation and immunity [17, 33].”
BackgroundQiao, B., Wang, H., Wang, C., Liang, M.-L., Huang, K., & Li, Y.-Q. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.03.018 · Cited by 23
Wang, N., Xu, T.-Y., Zhang, X., Li, J.-Y., Wang, Y.-X., Guo, X.-C., Li, S.-M., Wang, W.-F., & Li, D.-S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.048 · Cited by 23
Dias, I. R. D. S. R., Mok, S., Gordillo-Martínez, F., Khan, I., Hsiao, W. L., Law, B., Wong, V., & Liu, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00962 · Cited by 23
“…2014; Storr et al., 2011, 2015) (green boxes and arrows; includes NFKB1, which encodes the precursor protein of p50, one of the subunits of NF-κB, Karin and Ben-Neriah, 2000), JAK/STAT axis (purple boxes and arrows; includes STAT3) (Pothlichet et al., 2008; Miyazaki et al., 2015), and the…”
BackgroundInfluentialHalder, K., Banerjee, S., Ghosh, S., Bose, A., Das, S., Chowdhury, B., & Majumdar, S. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1078024 · Cited by 23
“The released NF-kB translocates into the nucleus and binds to the promoter region of MMP-9, leading to gene expression.(45) On the other hand, AP-1 is a nuclear transcription factor comprising homodimers and heterodimers of members of the Fos and Jun families.”
BackgroundGottardo, M. F., Ayala, M. M., Ferraris, J., Zárate, S., Pisera, D. A., Candolfi, M., Jaita, G., & Seilicovich, A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0388-4 · Cited by 23
Homocysteine regulates endothelin type B receptors in vascular smooth muscle cells.
Chen, Y., Zhang, H.-M., Liu, E.-Q., Xu, C.-B., & Zhang, Y.-P. (2016) · Vascular pharmacology · doi:10.1016/j.vph.2016.08.011 · Cited by 23
NFKB1 as a key player in Tumor biology: from mechanisms to therapeutic implications
Song, Z., Feng, Z., Wang, X., Li, J., & Zhang, D. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09974-2 · Cited by 22
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117367 · Cited by 22
The role of NF-κB-SOX9 signalling pathway in osteoarthritis
Tian, B., Zhang, L., Zheng, J., & Kang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37191 · Cited by 27
“Only after I κ B is phosphorylated and degraded by proteasome can NF-κ B dimer be released into the nucleus for transcriptional activation to regulate the expression of inflammatory factors [21,22].”
BackgroundSemwal, P., Painuli, S., Jamloki, A., Rauf, A., Rahman, M., Olatunde, A., Hemeg, H., Abu-Izneid, T., Naz, S., Bangar, S. P., et al. (2022) · Food reviews international (Print) · doi:10.1080/87559129.2022.2121407 · Cited by 22
Vázquez-Gómez, G., Karasová, M., Tylichová, Z., Kabátková, M., Hampl, A., Matthews, J. B., Neča, J., Cigánek, M., Machala, M., & Vondráček, J. (2022) · Cells · doi:10.3390/cells11040707 · Cited by 24
Zhang, H., Wang, Y., Zhou, X., Jiang, W., Wu, P., Liu, Y., Zhang, L., Mi, H., Jiang, J., Kuang, S., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112786 · Cited by 26
Chan, J. Y. H., & Chan, S. H. H. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.015 · Cited by 25
Ke, H.-Z., Lee, S., Kim, J., Liu, H.-C. S., & Yoo, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-47495-9 · Cited by 22
Meister, C., Thieme, K. G., Thieme, S., Köhler, A. M., Schmitt, K., Valerius, O., & Braus, G. (2019) · Biomolecules · doi:10.3390/biom9060238 · Cited by 22
“β-TrCP targets the physically interacting inhibitor of NF-κB for ubiquitination and subsequent degradation [38,91,92].”
Comparison of the Hepatoprotective Effects of the Three Main Stilbenes from Mulberry Twigs.
Jia, Y.-N., Peng, Y.-L., Zhao, Y., Cheng, X., Zhou, Y., Chai, C., Zeng, L., Pan, M., & Xu, L. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b07245 · Cited by 22
Cho, U., Choi, D.-H., Yoo, D., Park, S., & Hwang, H. (2019) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-019-0010-0 · Cited by 22
Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114
Lin, B., Qi, K., Li, H., Pheifer, N. S., Velliquette, D., & Leaman, D. W. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.002 · Cited by 23
“In addition, TRAF2 and TRAF6 activated by MAVS induce IKKα/ IKKβ/NF-κB essential modulator (NEMO) complex to transcriptionally regulate IFNs and inflammatory genes via NF-κB [10,11].”
BackgroundInfluentialLiu, X.-L., Xu, Q., Liu, W.-W., Yao, G.-D., Zhao, Y.-L., Xu, F., Hayashi, T., Fujisaki, H., Hattori, S., Tashiro, S.-I., et al. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3173-z · Cited by 22
Zeuner, M.-T., Vallance, T., Vaiyapuri, S., Cottrell, G., & Widera, D. (2017) · Mediators of Inflammation · doi:10.1155/2017/6209865 · Cited by 22
“To investigate if amyloid-β [1-42] can activate NF-κB in the absence of TLR2, we exposed U251-NF-κB-GFP-Luc cells to increasing concentrations of amyloid-β.”
BackgroundMethodInfluentialLoubaki, L., Chabot, D., Paré, I., Drouin, M., & Bazin, R. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.02.015 · Cited by 22
pVHL mediates K63-linked ubiquitination of IKKβ, leading to IKKβ inactivation.
Wang, Y., Zhao, W.-T., Gao, Q., Fan, L., Qin, Y.-Q., Zhou, H., Li, M., & Fang, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.009 · Cited by 22
Liu, B., Yao, Z., Song, L., Sun, C., Shen, C., Cheng, F., Cheng, Z., Zhang, R., & Liu, R. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117379 · Cited by 23
Tian, Y., Milic, J., Monasor, L. S., Chakraborty, R., Wang, S., Yuan, Y., Asare, Y., Behrends, C., Tahirović, S., & Bernhagen, J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04911-8 · Cited by 22
“As a central mediator of pro-inflammatory gene induction, the NF-κB pathway is activated by TNF triggering phosphorylation of IκB-α via the IKK complex and its degradation via the UPS, a process controlled by NEDDylated SCFβTrCP [17, 59, 60].”
BackgroundSunilkumar, S., VanCleave, A. M., McCurry, C. M., Toro, A. L., Stevens, S., Kimball, S., & Dennis, M. D. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104991 · Cited by 21
Aqil, F., Munagala, R., Agrawal, A., Jeyabalan, J., Tyagi, N., Rai, S., & Gupta, R. C. (2021) · Cancers · doi:10.3390/cancers13246248 · Cited by 21
Metadata
- Authors
- Karin, M., & Ben-Neriah, Y.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction University of California, San Diego, La Jolla, California, 92093-0636;
- ORCID
- Karin, Michael
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2000-04
- Volume
- 18
- Issue
- 1
- Pages
- 621-663
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2147921405
- Cited by
- 4,766
- References
- 243
- Citations by year
- 2026: 78 · 2025: 109 · 2024: 86 · 2023: 101 · 2022: 114 · 2021: 112 · 2020: 129 · 2019: 114 · 2018: 129 · 2017: 153 · 2016: 156 · 2015: 135 · 2014: 186 · 2013: 201 · 2012: 194
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01 CA76188, R01CA076188)
- National Institute of Allergy and Infectious Diseases (R01AI043477, R01 AI43477)
- National Institute of Environmental Health Sciences (R37ES004151, R37 ES04151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, IκB phosphorylation, ubiquitination, IκB kinase, IKKα, IKKβ, E3 ubiquitin ligase, proteolysis, NF-κB nuclear translocation, TNF signaling, IL-1 signaling, Rel family transcription factors, inflammation, transcriptional regulation
- MeSH terms
- NF-KappaB Inhibitor alpha, Amino Acid Sequence, Animals, DNA-Binding Proteins, Humans, Molecular Sequence Data, Phosphorylation, Transcription Factors, Ubiquitins, Signal Transduction, Down-Regulation, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Proteins, I-kappa B Kinase, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review